Federal Sentencing Defense
August 11, 2026
11 min read
Aaron M. Cohen

Eleventh Circuit Limits Loss Amount Attribution in Federal Fraud Sentencing: What United States v. Lopez Means for Florida Defendants

Your presentence report says $3.2 million. Your own conduct was $4,000. The Eleventh Circuit just vacated a Florida sentence built on exactly that gap.
Share this analysis:

Listen to Article

Part 1: Eleventh Circuit Limits Loss Amount Attribution in Federal Fraud Sentencing

United States v. Lopez vacates a sentence built on $3.2 million in loss for $4,000 of the defendant's own conduct.

0:000:00

If you are holding a presentence report that assigns you the entire loss figure for a scheme you touched one corner of, the Eleventh Circuit just handed you something worth using. On August 7, 2026, the court vacated a Southern District of Florida healthcare fraud sentence because the district court attributed roughly $3.2 million in intended Medicare loss to a defendant whose own conduct generated $4,000 in fraudulent claims.

Federal fraud sentencing loss amount attribution, Eleventh Circuit vacates $3.2 million loss figure under U.S.S.G. 1B1.3 relevant conduct

The district court charged a defendant with $3.2 million in intended Medicare loss for conduct that generated $4,000 in claims. The Eleventh Circuit vacated the sentence and sent it back.

Key Takeaways

  • The Eleventh Circuit vacated a Southern District of Florida sentence in United States v. Lopez, No. 25-11870 (11th Cir. Aug. 7, 2026), holding the government failed to prove the defendant agreed to join the conduct that generated the scheme's losses.
  • Under U.S.S.G. § 1B1.3(a)(1)(B), scope of the agreement comes first and foreseeability comes last. The three requirements are conjunctive, not alternatives.
  • A defendant's mere awareness that he was part of a larger scheme is not enough to put another person's criminal activity inside the scope of his agreement.
  • The math is the whole case: $3,248,540 in loss is a 16-level enhancement under § 2B1.1(b)(1), while $4,000 carries no loss enhancement at all.
  • The panel applied buyer-seller principles, so someone who sold information in discrete transactions is not automatically a joint venturer in whatever the buyer billed next.

What Actually Happened

The defendant pleaded guilty to two counts of health care fraud under 18 U.S.C. § 1347 with no plea agreement. He admitted that between February and September 2021 he obtained Medicare beneficiary cards and sold them knowing they would be used to bill fraudulent claims. On one date in February 2021 he bought ten cards. A clinic used three of them and submitted two claims totaling $4,000.

That same clinic went on to submit approximately $3,248,540 in fraudulent claims and collected roughly $1.5 million from Medicare. The presentence report took the full figure, applied the 16-level enhancement under U.S.S.G. § 2B1.1(b)(1), and produced an advisory range of 37 to 46 months. The court imposed 30 months, three years of supervised release, and about $1.5 million in restitution.

Defense counsel objected. The dispute was not whether a fraud occurred. It was whose fraud the defendant had agreed to join. The district court overruled the objection on the ground that the defendant was working in concert as part of a greater scheme and that substantial losses were foreseeable given his statements to others in the conspiracy.

🚨 Case Alert

The Eleventh Circuit vacated and remanded. The panel did not hold that the defendant was innocent of anything, and it did not hold that $3.2 million was the wrong number for the scheme. It held that the government failed to put on substantial evidence of an agreement between this defendant and the entity that generated those losses, and that without proof of that agreement the losses are not his relevant conduct.

The precision of that holding is the whole value of the opinion. It is a proof ruling, not an absolution, and that is exactly what makes it usable in the next case.

Ten Medicare beneficiary cards and two fraudulent claim forms, the $4,000 in conduct actually attributable to the defendant in United States v. Lopez
Ten cards. Three used. Two claims totaling $4,000. The defense theory in this case fit inside two numbers, and that is why it survived appellate review.

The Order of Operations Prosecutors Keep Skipping

Almost every federal fraud sentencing turns on a number calculated before the defense ever sees it. Probation pulls the aggregate scheme loss from the government's summary. The prosecutor defends it with foreseeability. The court adopts it. The defendant is left arguing about a figure never tied to anything he personally agreed to do.

U.S.S.G. § 1B1.3(a)(1)(B) does not permit that shortcut. Since the 2015 restructuring of the relevant conduct guideline, the three requirements sit in the guideline text itself and they are conjunctive. Another person's conduct is attributable to a defendant only when it was within the scope of the criminal activity the defendant agreed to jointly undertake, in furtherance of that activity, and reasonably foreseeable in connection with it.

Scope comes first. Foreseeability comes last.

Eleventh Circuit appellate panel vacating a federal healthcare fraud sentence over relevant conduct scope findings
"Acts of others that were not within the scope of the defendant's agreement, even if those acts were known or reasonably foreseeable to the defendant, are not relevant conduct under subsection (a)(1)(B)."United States v. Lopez, No. 25-11870 (11th Cir. Aug. 7, 2026)

That forecloses the argument prosecutors have been winning on for years. A defendant can know, with total clarity, that he is one input into a large fraudulent operation and still not have agreed to jointly undertake that operation. In the panel's words, a defendant's mere awareness that he was part of a larger scheme is alone insufficient to show that another individual's criminal activity was within the scope of the defendant's jointly undertaken criminal activity.

The court also reached for something most white collar defense attorneys associate with drug cases. It applied buyer-seller principles, citing the rule that where the buyer's purpose is merely to buy and the seller's purpose is merely to sell, with no understanding beyond the sales agreement, no conspiracy has been shown. Someone who sells beneficiary information to a biller is, on some records, a seller. The transaction is not automatically a joint venture in whatever the buyer does next.

Exposure, the Guideline Math, and the Government's Burden

Health care fraud under 18 U.S.C. § 1347 carries up to 10 years per count. Conspiracy under 18 U.S.C. § 1349 carries the same penalty as the underlying offense. The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b, adds 10 years per count plus mandatory program exclusion. Those maximums are not what drives the sentence. The loss figure does.

⚖️ Key Legal Point

Run the numbers here and the stakes are obvious. At $3,248,540 the loss enhancement is 16 levels. At $4,000 there is no loss enhancement at all, because the guideline gives no increase for loss of $6,500 or less. That is not a marginal adjustment.

The burden question matters as much. When a defendant disputes the loss calculation, the government must prove the facts supporting the enhancement by a preponderance of the evidence, measured against a substantial evidence standard: more than a mere scintilla, meaning relevant evidence a reasonable mind might accept as adequate to support the conclusion. The government does not get to start with the aggregate number and dare the defendant to subtract from it.

One caution. Restitution runs on a different track. Under the Mandatory Victims Restitution Act, 18 U.S.C. § 3663A, a scheme offense can support restitution to persons directly harmed by the defendant's criminal conduct in the course of the scheme. A guideline win on scope does not automatically erase a restitution order, but the same evidentiary gap is the gap to press on the restitution number.

Sixteen levels separate those two numbers. The government does not get to start with the aggregate figure and dare the defendant to subtract from it.
Presentence investigation report with the aggregate scheme loss circled beside the far smaller figure attributable to the defendant's own conduct

Critical Mistakes People Make Early

The loss fight is usually lost long before sentencing, in decisions made by people who did not know they were making them.

Talking to agents without counsel. The district court leaned on this defendant's own statements to others in the scheme. Statements to agents work the same way, and inconsistencies become their own charge under 18 U.S.C. § 1001. HHS-OIG subpoena defense begins with silence and counsel.

Pleading open without a loss stipulation. Pleading without an agreement leaves the number entirely to probation and the court. Sometimes that is the right call. It should be a decision, not a default.

Filing generic PSR objections. Generic objections lose. The objection that works identifies what the defendant agreed to do, names the specific transactions inside that agreement, and forces the government to connect every other dollar to it.

💡 Practical Tip

Waiting for the indictment is the costliest error on this list. By the time a federal target letter or a grand jury subpoena arrives, the government has been assembling billing data for months or years. Pre-indictment defense work is where the loss theory can still be narrowed, whether the case is a telemedicine fraud matter, a DME billing case, or a beneficiary information prosecution.

How to Litigate Scope After Lopez

Make the district court do the analysis in the correct order, and build a record that makes skipping it reversible.

Force an individualized finding. Ask the court on the record to identify what criminal activity this defendant agreed to jointly undertake, before any discussion of foreseeability. A transcript in which the court moves straight to foreseeability is now an appellate issue.

Separate knowledge from agreement. Concede what is true. The client knew there was a larger operation. Then insist that knowledge is not the finding the guideline requires, and make the government identify its evidence of agreement.

Map the transactions. Tie the client's conduct to specific dates, counts, and dollars. Here the defense theory fit in two numbers, ten cards and $4,000.

Use the buyer-seller framing where the facts support it. A defendant who sold information in discrete transactions, with no ongoing role in the biller's operation, stands differently than one embedded in the billing entity.

🛡️ Defense Strategy

Preserve everything in writing. Written guideline objections, a federal sentencing memorandum that walks the scope analysis step by step, a 18 U.S.C. § 3553(a) argument built on the corrected number, and a clean objection on the record after the court rules. Lopez was reviewable because the objection was preserved.

Why Timing Matters Right Now

Two clocks are running. The first is in cases already in the pipeline. Any defendant awaiting sentencing in the Southern or Middle District of Florida, or whose direct appeal is still open, should be evaluating whether the loss figure in the presentence report rests on scope findings or on foreseeability language. Guideline objections have deadlines, and appellate issues are waived if not preserved.

The second is the guideline amendment package taking effect November 1, 2026, which rewrites the economic loss rules at U.S.S.G. § 2B1.1. A defendant resentenced after that date may get both a corrected attribution analysis and a restructured loss table. For someone whose sentencing date is still flexible, that combination is worth analyzing rather than leaving to the calendar.

South Florida federal criminal defense practice sees the same pattern in case after case. A handful of organizers build the operation. Dozens of peripheral participants supply pieces of it. Then everyone gets measured against the same aggregate number. Lopez is the case that says the measuring has to be done one defendant at a time.

Common Questions

Can the government hold me responsible for the entire fraud scheme at sentencing?
Only if it proves the conduct generating those losses fell within the scope of the criminal activity you agreed to jointly undertake. Under U.S.S.G. § 1B1.3(a)(1)(B), the court must make that individualized finding first. Knowing a larger scheme existed, and being able to foresee its losses, is not by itself enough to attribute the whole figure to you.
What is the difference between foreseeability and scope in a federal sentencing guideline calculation?
Scope asks what criminal activity you actually agreed to undertake with others. Foreseeability asks whether you could anticipate what those others would do. The guideline requires both, in that order. The Eleventh Circuit held that acts outside the scope of your agreement are not relevant conduct even when they were known or reasonably foreseeable to you.
How much does the loss amount change a federal fraud sentence?
Enormously. Under U.S.S.G. § 2B1.1(b)(1), loss of $6,500 or less adds nothing to the offense level, while loss above $1.5 million adds 16 levels. In Lopez, the difference between the $4,000 attributable to the defendant's own conduct and the $3.2 million charged to the scheme was the entire sentencing exposure.
Does a successful loss objection also reduce restitution?
Not automatically. Restitution under the Mandatory Victims Restitution Act, 18 U.S.C. § 3663A, follows its own rules and can reach losses caused by the defendant's conduct in the course of a scheme. The same proof problem that defeats a guideline enhancement is often the strongest argument against an inflated restitution figure, but it must be raised separately.
I sold information or provided a service to someone who turned out to be committing Medicare fraud. Am I responsible for their billing?
Not necessarily. The Eleventh Circuit applied buyer-seller principles in Lopez, recognizing that a transaction between a seller and a buyer, without an understanding beyond the sale itself, does not establish a joint criminal undertaking. What the buyer billed afterward is not automatically your relevant conduct, and that distinction is worth litigating early.

Facing a Federal Healthcare Fraud Investigation or Sentencing in Florida?

AMC Defense Law represents physicians, clinic owners, billers, marketers, patient recruiters, and corporate officers in federal healthcare fraud matters across the Southern and Middle Districts of Florida and nationwide. Physician federal investigation defense and federal investigation defense for peripheral participants are both built the same way here: early intervention, disciplined guideline litigation, and sentencing positioning that treats the loss figure as something to be proven rather than accepted.

Aaron M. Cohen federal defense attorney arguing a guideline objection at a federal sentencing hearing in Florida, AMC Defense Law

Discretion is the rule. Every consultation is confidential. Call 561.542.5494 or contact the firm through amcdefenselaw.com to schedule a confidential case review.

If you or your loved ones have been arrested or are facing a federal sentencing in Florida, call Aaron M. Cohen for a confidential consultation, 24 hours a day, to get help.

This article was written by Michael Hursey, Esq., and Aaron M. Cohen, Esq., of AMC Defense Law. Michael Hursey, Esq. is Of Counsel to AMC Defense Law. He has practiced criminal defense and appellate law for more than 45 years. He is a member of The Florida Bar and is admitted to the Supreme Court of the United States, the United States Courts of Appeals for the Fourth, Fifth, Seventh, and Eleventh Circuits, and multiple United States District Courts in Florida, Illinois, Michigan, Texas, and New Jersey. Before entering private practice he served as a federal prosecutor in Miami, representing the United States Department of State and the Department of Justice in international extradition matters. His practice includes drug conspiracy and trafficking, fraud and economic crimes, weapons offenses, post-conviction relief, and extradition.

Aaron M. Cohen, Esq. is the founding attorney of AMC Defense Law (The Law Offices of Aaron M. Cohen, P.A.), a criminal defense firm based in Boca Raton, Florida. With more than 30 years of experience as a federal criminal defense attorney, Mr. Cohen represents individuals and entities in complex federal and state criminal investigations and prosecutions nationwide. He is admitted to practice law in Florida, New York, New Jersey, and the District of Columbia, and is admitted in the United States District Courts for the Southern, Middle, and Northern Districts of Florida, the District of Columbia, the Southern and Eastern Districts of New York, the District of New Jersey, the Eastern District of Michigan, and the Southern District of West Virginia, as well as the United States Court of Appeals for the Eleventh Circuit. Mr. Cohen is available pro hac vice in federal districts nationwide for clients requiring experienced criminal defense counsel in complex or sensitive matters.

This article is for general informational purposes only and does not constitute legal advice. Reading this article does not create an attorney-client relationship. Every federal investigation and sentencing involves unique facts. Anyone who believes they may be under investigation, or who is facing a federal sentencing, should consult experienced federal criminal defense counsel before taking any action.

If the legal developments discussed in this article affect your case, don't wait.

Aaron M. Cohen, Principal Attorney

Aaron M. Cohen

Principal Attorney

Aaron M. Cohen is a nationally recognized criminal defense attorney with over 30 years of experience representing individuals and entities in complex criminal investigations and prosecutions across the United States.

View Attorney Profile
Continue reading
30+ Years of Federal & State Defense Experience

Need Expert Legal Defense?

Facing federal gun or drug charges in South Florida? The DOJ's aggressive enforcement climate demands experienced federal defense counsel. Our team understands the complex intersection of firearms and narcotics law.

All consultations are completely confidential